Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study

BACKGROUND: Peritoneal metastasis is the most frequent failure in gastric cancer. This study evaluated the role of prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion (CHIP) in patients after D2 dissection. METHODS: Gastric cancer patients after D2 dissection were enrolled in this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lucheng, Xu, Zhizheng, Wu, Yajun, Liu, Pengyuan, Qian, Jianing, Yu, Shuhuan, Xia, Bing, Lai, Jianjun, Ma, Shenglin, Wu, Zhibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461269/
https://www.ncbi.nlm.nih.gov/pubmed/32867714
http://dx.doi.org/10.1186/s12885-020-07339-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461269/
https://www.ncbi.nlm.nih.gov/pubmed/32867714
http://dx.doi.org/10.1186/s12885-020-07339-6

Ejemplares similares